Programme Reports Zero PPH-Linked Maternal Deaths at 77 Kaduna Facilities Using E-MOTIVE
A maternal-health programme says 77 participating facilities across nine Kaduna State LGAs have recorded no maternal deaths linked to postpartum haemorrhage since August 2025 after frontline workers began using the E-MOTIVE approach.
The result is based on programme data. It has not been independently audited and does not mean Kaduna State as a whole has eliminated deaths from severe bleeding after childbirth.
The intervention trained 77 community health extension workers and nine clinical mentors across the participating facilities.
Why severe bleeding after childbirth matters
Postpartum haemorrhage, or PPH, can become life-threatening within a short time.
At primary healthcare centres, the speed at which heavy blood loss is recognised and treated can determine whether a woman is stabilised, referred safely or deteriorates before reaching higher-level care.
E-MOTIVE is designed to improve that early response.
Health workers use calibrated tools to measure blood loss and respond with a treatment bundle that can include uterine massage, medicines to control bleeding, tranexamic acid, IV fluids, clinical examination and referral when necessary.
Nine LGAs are participating
The programme covers facilities in:
- Kaduna North;
- Kaduna South;
- Igabi;
- Soba;
- Sabon Gari;
- Makarfi;
- Kaura;
- Jema’a;
- Zangon Kataf.
One CHEW was trained at each of the 77 participating facilities, alongside nine clinical mentors.
The reported outcome applies to these facilities only.
Mothers describe emergency treatment at PHCs
Published reporting documents women whose heavy bleeding after childbirth was treated at participating facilities.
They include Hadiza Umar, treated at Mando PHC in Igabi LGA, and Aishatu Isah, whose bleeding was managed at Abdu Kwari PHC.
Their experiences show how the intervention is being used in individual emergencies.
They do not establish overall programme effectiveness on their own.
What the zero-death claim does — and does not — show
Programme officials report zero PPH-linked maternal deaths in the participating facilities since August 2025.
That is an important outcome claim, but several questions remain unanswered.
The public record reviewed does not independently establish:
- the total number of PPH cases treated;
- how many women required referral;
- whether mortality records were complete across all 77 facilities;
- outcomes after referral;
- or whether the zero-death figure can be reproduced from state and facility records.
The figure should therefore remain clearly attributed to the programme.
Other Kaduna E-MOTIVE work is separate
Other organisations are also supporting maternal-health services in Kaduna.
TAConnect, working with the state government, supports E-MOTIVE and PPH care in additional primary, secondary and teaching facilities, including nine hospitals under a separate intervention.
Those projects are related but do not form part of the same 77-facility outcome dataset.
Their facility numbers, training totals and results should not be combined.
Medicines and supplies can determine whether training works
Health-worker training alone is not enough.
Facilities also need reliable access to medicines, calibrated blood-loss tools, IV fluids, referral transport and other essential supplies.
Separate Kaduna programme assessments have identified continuing concerns around commodity availability, oxytocin cold-chain management, calibrated drape use and labour-ward conditions.
Those gaps can limit how effectively trained workers respond to emergencies.
Referral is part of safe treatment
E-MOTIVE is intended to improve early detection and immediate care.
It does not remove the need for referral when a woman requires blood transfusion, surgery or specialist obstetric treatment.
A strong programme should therefore not be judged simply by how few women are referred.
The more important questions are whether dangerous bleeding is recognised early, treatment starts quickly and patients who need higher-level care reach it in time.
Can the reported gains be sustained?
The longer-term test is whether the reported results continue when intensive partner support reduces.
That will depend on whether Kaduna can maintain:
- essential medicines and supplies;
- staff mentorship and refresher training;
- accurate mortality and referral records;
- functioning emergency transport;
- and routine financing for the intervention.
The strongest evidence of success will be sustained maternal outcomes that can be independently verified.
What is established
The current record supports four central facts:
- 77 CHEWs and nine clinical mentors were trained;
- 77 facilities across nine Kaduna LGAs are participating;
- E-MOTIVE is being used to detect and manage postpartum haemorrhage;
- programme officials report zero PPH-linked maternal deaths in participating facilities since August 2025.
What remains unresolved is independent verification of that outcome, complete referral and case data, commodity stock-out frequency and whether similar gains exist outside the participating facilities.
For now, the evidence supports a measured conclusion:
The Kaduna E-MOTIVE programme reports zero PPH-linked maternal deaths at 77 participating facilities since August 2025, while independent verification and wider statewide outcomes remain unresolved.
